Results 201 to 210 of about 1,751,474 (312)

The Meandrous Route of Rilpivirine in the Search for the Miraculous Drug to Treat HIV Infections. [PDF]

Viruses
De Clercq E.
europepmc   +1 more source

Long‐Acting Therapeutics in Pediatric Health: Bridging Innovation and Access

Clinical Pharmacology &Therapeutics, EarlyView.
Children have distinct therapeutic needs arising from age‐dependent physiology, disease epidemiology, formulation requirements, dosing considerations, and safety vulnerabilities. Despite substantial reductions in childhood mortality over the past three decades, nearly 5 million children under five died in 2023, with infectious diseases continuing to ...
Prajith Venkatasubramanian, Moherndran Archary, Daniel B. Hawcutt, Rachel Daley, Edmund Capparelli, Adeniyi Olagunju   +5 more
wiley   +1 more source

Factors Associated With Recent HIV Infections Among Newly HIV Diagnosed in Rwanda. [PDF]

J Acquir Immune Defic Syndr
Remera E, Chammartin F, Nsanzimana S, Malamba SS, Rwibasira GN, Riedel DJ, Forrest JI, Mutesa L, Ford N, Ahmed A, Condo JU, Karera S, Mills EJ, Bucher HC.   +13 more
europepmc   +1 more source

Diagnosing HIV infection [PDF]

Clinical Medicine, 2003
openaire   +2 more sources

Trust, but Verify: Translating Dosing Evidence to Understudied Populations in Low‐ and Middle‐Income Countries

Clinical Pharmacology &Therapeutics, EarlyView.
Drug dosing recommendations derived from healthy volunteers and selected preregistration populations may not translate reliably to physiologically distinct or understudied groups, particularly in low‐ and middle‐income countries. Using a metformin–dolutegravir drug interaction study and colistin pharmacokinetic study from South Africa, we illustrate ...
Roland van Rensburg, Veshni Pillay‐Fuentes Lorente, Eric Decloedt   +2 more
wiley   +1 more source

HIV-1 drug resistance among pregnant and breastfeeding mothers and its association with paediatric HIV infections in the Dolutegravir era in Uganda. [PDF]

J Antimicrob Chemother
Kapaata A, Byamukama D, Kankaka EN, Asio JN, Ayitewala A, Ssewanyana I, Ssengooba W, Biraro IA, Obondo SJ, Sentalo Bagaya B, Nakiyingi L, Mayanja-Kizza H, Balinda SN, Kikaire B.   +13 more
europepmc   +1 more source

Establishment of pediatric reference ranges for circulating naïve and memory T and B cell subsets guided by the human immunophenotyping consortium standardization initiative: A large, single center U.S. experience

Cytometry Part B: Clinical Cytometry, EarlyView.
Abstract Our knowledge of the immune system continues to expand at a rapid pace, and this coupled with technological advances now enables us to interrogate both the breadth and the depth of the immune response at levels without precedent. This has also facilitated rapidly integrating some of this carefully vetted knowledge into clinical practice ...
Aaruni Khanolkar, Aisha Ahmed
wiley   +1 more source

Contribution of HIV transmission bursts to future HIV infections. [PDF]

AIDS
Billock RM, France AM, Saduvala N, Panneer N, Hallmark CJ, Wertheim JO, Oster AM.   +6 more
europepmc   +1 more source

Diagnostic Usefulness of Cell Block Samples in Fluid Overload‐Associated Large B‐Cell Lymphoma

Diagnostic Cytopathology, EarlyView.
ABSTRACT Fluid overload‐associated B‐cell lymphoma (FO‐LBCL) is a B‐cell neoplasm that presents as serous effusions without detectable tumor masses and Kaposi sarcoma‐associated herpesvirus (KSHV)/human herpesvirus 8 (HHV8) infection. Here, we report a case of an 81‐year‐old female patient with FO‐LBCL (Stage IVA) who presented with pericardial and ...
Hiroyuki Okanishi, Hiroko Kuwabara, Hiroko Nakayama, Mayo Odaka, Kozue Ariga, Isako Kataoka, Mari Tomiuka, Mayumi Uragami, Chihiro Deguchi, Shizuka Ono, Reika Takeda, Yoshitaka Kurisu, Yoshinobu Hirose, Yuuki Kinoshita, Taiji Yokote   +14 more
wiley   +1 more source

Recent HIV infections and associated risk factors among newly diagnosed individuals in South Korea (2016-2023). [PDF]

Sci Rep
Wang JS, Kim EJ, Kim G, Kim S, Kim HM, Lee YJ, Hong HG, Kim MS, Jo NR, Heo TY, Kim K, Kim S, Yu J, Han MG.   +13 more
europepmc   +1 more source